Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
01 01 2022
Historique:
pubmed: 9 11 2021
medline: 19 2 2022
entrez: 8 11 2021
Statut: ppublish

Résumé

Advanced imaging for patient selection in mechanical thrombectomy is not widely available. To compare the clinical outcomes of patients selected for mechanical thrombectomy by noncontrast computed tomography (CT) vs those selected by computed tomography perfusion (CTP) or magnetic resonance imaging (MRI) in the extended time window. This multinational cohort study included consecutive patients with proximal anterior circulation occlusion stroke presenting within 6 to 24 hours of time last seen well from January 2014 to December 2020. This study was conducted at 15 sites across 5 countries in Europe and North America. The duration of follow-up was 90 days from stroke onset. Computed tomography with Alberta Stroke Program Early CT Score, CTP, or MRI. The primary end point was the distribution of modified Rankin Scale (mRS) scores at 90 days (ordinal shift). Secondary outcomes included the rates of 90-day functional independence (mRS scores of 0-2), symptomatic intracranial hemorrhage, and 90-day mortality. Of 2304 patients screened for eligibility, 1604 patients were included, with a median (IQR) age of 70 (59-80) years; 848 (52.9%) were women. A total of 534 patients were selected to undergo mechanical thrombectomy by CT, 752 by CTP, and 318 by MRI. After adjustment of confounders, there was no difference in 90-day ordinal mRS shift between patients selected by CT vs CTP (adjusted odds ratio [aOR], 0.95 [95% CI, 0.77-1.17]; P = .64) or CT vs MRI (aOR, 0.95 [95% CI, 0.8-1.13]; P = .55). The rates of 90-day functional independence (mRS scores 0-2 vs 3-6) were similar between patients selected by CT vs CTP (aOR, 0.90 [95% CI, 0.7-1.16]; P = .42) but lower in patients selected by MRI than CT (aOR, 0.79 [95% CI, 0.64-0.98]; P = .03). Successful reperfusion was more common in the CT and CTP groups compared with the MRI group (474 [88.9%] and 670 [89.5%] vs 250 [78.9%]; P < .001). No significant differences in symptomatic intracranial hemorrhage (CT, 42 [8.1%]; CTP, 43 [5.8%]; MRI, 15 [4.7%]; P = .11) or 90-day mortality (CT, 125 [23.4%]; CTP, 159 [21.1%]; MRI, 62 [19.5%]; P = .38) were observed. In patients undergoing proximal anterior circulation mechanical thrombectomy in the extended time window, there were no significant differences in the clinical outcomes of patients selected with noncontrast CT compared with those selected with CTP or MRI. These findings have the potential to widen the indication for treating patients in the extended window using a simpler and more widespread noncontrast CT-only paradigm.

Identifiants

pubmed: 34747975
pii: 2785854
doi: 10.1001/jamaneurol.2021.4082
pmc: PMC8576630
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

22-31

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS121154
Pays : United States

Commentaires et corrections

Type : ErratumIn
Type : CommentIn

Auteurs

Thanh N Nguyen (TN)

Department of Neurology, Boston University School of Medicine, Boston, Massachusetts.
Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.

Mohamad Abdalkader (M)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.

Simon Nagel (S)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Muhammad M Qureshi (MM)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.
Department of Radiation Oncology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.

Marc Ribo (M)

Stroke Unit, Department of Neurology, Hospital Universitario Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.

Francois Caparros (F)

University Lille, Inserm, Centre Hospitalier Universitaire de Lille, U1172, LilNCog-Lille Neuroscience & Cognition, Lille, France.

Diogo C Haussen (DC)

Department of Neurology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, Georgia.

Mahmoud H Mohammaden (MH)

Department of Neurology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, Georgia.

Sunil A Sheth (SA)

Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas.

Santiago Ortega-Gutierrez (S)

Department of Neurology, University of Iowa, Iowa City.

James E Siegler (JE)

Department of Neurology, Cooper University Hospital, Camden, New Jersey.

Syed Zaidi (S)

Department of Neurology, University of Toledo, Toledo, Ohio.

Marta Olive-Gadea (M)

Stroke Unit, Department of Neurology, Hospital Universitario Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.

Hilde Henon (H)

University Lille, Inserm, Centre Hospitalier Universitaire de Lille, U1172, LilNCog-Lille Neuroscience & Cognition, Lille, France.

Markus A Möhlenbruch (MA)

Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

Alicia C Castonguay (AC)

Department of Neurology, University of Toledo, Toledo, Ohio.

Stefania Nannoni (S)

Stroke Center, Neurology Service, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Johannes Kaesmacher (J)

Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Inselspital, Bern, Switzerland.
Institute of Diagnostic, Interventional and Pediatric Radiology, University Hospital Bern, Inselspital, Bern, Switzerland.

Ajit S Puri (AS)

Neurointerventional Radiology, Department of Radiology, University of Massachusetts, Worcester, Massachusetts.

Fatih Seker (F)

Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

Mudassir Farooqui (M)

Department of Neurology, University of Iowa, Iowa City.

Sergio Salazar-Marioni (S)

Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas.

Anna L Kuhn (AL)

Neurointerventional Radiology, Department of Radiology, University of Massachusetts, Worcester, Massachusetts.

Artem Kaliaev (A)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.

Behzad Farzin (B)

Interventional Neuroradiology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.

William Boisseau (W)

Interventional Neuroradiology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.

Hesham E Masoud (HE)

Department of Neurology, SUNY Upstate Medical University Hospital, Syracuse, New York.

Carlos Ynigo Lopez (CY)

Department of Neurology, SUNY Upstate Medical University Hospital, Syracuse, New York.

Ameena Rana (A)

Department of Neurology, Cooper University Hospital, Camden, New Jersey.

Samer Abdul Kareem (SA)

Neuroscience and Stroke Program, Bon Secours Mercy Health St Vincent Hospital, Toledo, Ohio.

Anvitha Sathya (A)

Department of Neurology, Boston University School of Medicine, Boston, Massachusetts.

Piers Klein (P)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.

Mohammad W Kassem (MW)

Neuroscience and Stroke Program, Bon Secours Mercy Health St Vincent Hospital, Toledo, Ohio.

Peter A Ringleb (PA)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Charlotte Cordonnier (C)

University Lille, Inserm, Centre Hospitalier Universitaire de Lille, U1172, LilNCog-Lille Neuroscience & Cognition, Lille, France.

Jan Gralla (J)

Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Inselspital, Bern, Switzerland.

Urs Fischer (U)

Department of Neurology, University Hospital Bern, University of Bern, Bern, Switzerland.
Department of Neurology, University Hospital Basel, University of Basel, Switzerland.

Patrik Michel (P)

Stroke Center, Neurology Service, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Tudor G Jovin (TG)

Department of Neurology, Cooper University Hospital, Camden, New Jersey.

Jean Raymond (J)

Interventional Neuroradiology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.

Osama O Zaidat (OO)

Neuroscience and Stroke Program, Bon Secours Mercy Health St Vincent Hospital, Toledo, Ohio.

Raul G Nogueira (RG)

Department of Neurology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH